000153632 001__ 153632
000153632 005__ 20240229123046.0
000153632 0247_ $$2doi$$a10.1007/s00103-020-03097-9
000153632 0247_ $$2pmid$$apmid:32034443
000153632 0247_ $$2ISSN$$a1436-9990
000153632 0247_ $$2ISSN$$a1437-1588
000153632 0247_ $$2altmetric$$aaltmetric:75577226
000153632 037__ $$aDKFZ-2020-00355
000153632 041__ $$ager
000153632 082__ $$a610
000153632 1001_ $$aWiessner, Christian$$b0
000153632 245__ $$a[Persons with migration background in the German National Cohort (NAKO)-sociodemographic characteristics and comparisons with the German autochthonous population].
000153632 260__ $$aHeidelberg$$bSpringer$$c2020
000153632 3367_ $$2DRIVER$$aarticle
000153632 3367_ $$2DataCite$$aOutput Types/Journal article
000153632 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1583757300_24398
000153632 3367_ $$2BibTeX$$aARTICLE
000153632 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000153632 3367_ $$00$$2EndNote$$aJournal Article
000153632 500__ $$a2020 Mar;63(3):279-289.
000153632 520__ $$aPersons with a migration background (PmM) as a population group usually differ from the autochthonous population in terms of morbidity, mortality, and use of the health care system, but they participate less frequently in health studies. The PmM group is very heterogeneous, which has hardly been taken into account in studies so far.Sociodemographic characteristics of PmM in the NAKO health study (age, sex, time since migration, education) are presented. In addition, it is examined through an example whether migration background is related to the use of cancer screening for colorectal cancer (hemoccult test).Data of the first 101,816 persons of the NAKO were analyzed descriptively and cartographically. The migration background was assigned on the basis of the definition of the Federal Statistical Office, based on nationality, country of birth, year of entry, and country of birth of the parents.Overall, the PmM proportion is 16.0%. The distribution across the 18 study centers varies considerably between 6% (Neubrandenburg) and 33% (Düsseldorf). With 153 countries of origin, most countries are represented in the NAKO. All variables show clear differences between the different regions of origin. In the hemoccult test, persons of Turkish origin (OR = 0.67) and resettlers (OR = 0.60) have a lower participation rate. PmM born in Germany do not differ in this respect from the autochthonous population (OR = 0.99).PmM in the NAKO are a very heterogeneous group. However, due to the sample size, individual subgroups of migrants can be studied separately with respect to region of origin.
000153632 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000153632 588__ $$aDataset connected to CrossRef, PubMed,
000153632 7001_ $$aKeil, Thomas$$b1
000153632 7001_ $$aKrist, Lilian$$b2
000153632 7001_ $$aZeeb, Hajo$$b3
000153632 7001_ $$aDragano, Nico$$b4
000153632 7001_ $$aSchmidt, Börge$$b5
000153632 7001_ $$aAhrens, Wolfgang$$b6
000153632 7001_ $$aBerger, Klaus$$b7
000153632 7001_ $$aCastell, Stefanie$$b8
000153632 7001_ $$aFricke, Julia$$b9
000153632 7001_ $$aFührer, Amand$$b10
000153632 7001_ $$aGastell, Sylvia$$b11
000153632 7001_ $$0P:(DE-He78)e0ac0d57cdb66d87f2d95ae5f6178c1b$$aGreiser, Halina$$b12$$udkfz
000153632 7001_ $$0P:(DE-He78)0311ebf3415e41860b4e2c56fbae6919$$aGuo, Feng$$b13$$udkfz
000153632 7001_ $$aJaeschke, Lina$$b14
000153632 7001_ $$aJochem, Carmen$$b15
000153632 7001_ $$aJöckel, Karl-Heinz$$b16
000153632 7001_ $$0P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aKaaks, Rudolf$$b17$$udkfz
000153632 7001_ $$0P:(DE-He78)13aa5fe9d9961c9fd67193befb0dcf88$$aKoch-Gallenkamp, Lena$$b18$$udkfz
000153632 7001_ $$aKrause, Gérard$$b19
000153632 7001_ $$aKuss, Oliver$$b20
000153632 7001_ $$aLegath, Nicole$$b21
000153632 7001_ $$aLeitzmann, Michael$$b22
000153632 7001_ $$aLieb, Wolfgang$$b23
000153632 7001_ $$aMeinke-Franze, Claudia$$b24
000153632 7001_ $$aMeisinger, Christa$$b25
000153632 7001_ $$aMikolajczyk, Rafael$$b26
000153632 7001_ $$aObi, Nadia$$b27
000153632 7001_ $$aPischon, Tobias$$b28
000153632 7001_ $$aSchipf, Sabine$$b29
000153632 7001_ $$aSchmoor, Claudia$$b30
000153632 7001_ $$aSchramm, Sara$$b31
000153632 7001_ $$aSchulze, Matthias B$$b32
000153632 7001_ $$aSowarka, Nicole$$b33
000153632 7001_ $$aWaniek, Sabina$$b34
000153632 7001_ $$aWigmann, Claudia$$b35
000153632 7001_ $$aWillich, Stefan N$$b36
000153632 7001_ $$aBecher, Heiko$$b37
000153632 773__ $$0PERI:(DE-600)1470303-8$$a10.1007/s00103-020-03097-9$$n3$$p279-289$$tBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz$$v63$$x1437-1588$$y2020
000153632 909CO $$ooai:inrepo02.dkfz.de:153632$$pVDB
000153632 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e0ac0d57cdb66d87f2d95ae5f6178c1b$$aDeutsches Krebsforschungszentrum$$b12$$kDKFZ
000153632 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0311ebf3415e41860b4e2c56fbae6919$$aDeutsches Krebsforschungszentrum$$b13$$kDKFZ
000153632 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aDeutsches Krebsforschungszentrum$$b17$$kDKFZ
000153632 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)13aa5fe9d9961c9fd67193befb0dcf88$$aDeutsches Krebsforschungszentrum$$b18$$kDKFZ
000153632 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000153632 9141_ $$y2020
000153632 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000153632 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000153632 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000153632 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBUNDESGESUNDHEITSBLA : 2017
000153632 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000153632 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000153632 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000153632 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000153632 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000153632 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x1
000153632 980__ $$ajournal
000153632 980__ $$aVDB
000153632 980__ $$aI:(DE-He78)C020-20160331
000153632 980__ $$aI:(DE-He78)C070-20160331
000153632 980__ $$aUNRESTRICTED